TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004
TCL Archive In Brief: Lasagna Committee Report Finalized; Robinson Replaces Schmidt On MSK Boards July 13, 1990
TCL Archive DCPC Board Ponders Screening Recommendations: Should NCI Have Policies? If So, What Will They Be? September 26, 1986